Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis

NCT: NCT06383585 · ACTIVE_NOT_RECRUITING

NCT IDNCT06383585
StatusACTIVE_NOT_RECRUITING
Start Date2024-12-05
Completion2026-12-31
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

This project intends to explore and validate the utility of new MRI pulse sequence, 3D DL oZTEo, in the detection of osseous erosions of the hand in patients with inflammatory arthritis. The detection of osseous structural changes, such as erosive disease, is routinely assessed in patients with rheumatic conditions such as rheumatoid arthritis, as it alters clinical management, and in some cases assists in diagnosis. Currently, this is most often assessed with radiography and conventional MRI.

Frequently Asked Questions

What is 3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis?

3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis is a clinical trial registered under NCT06383585. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06383585?

The current status of NCT06383585 (3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis) is: ACTIVE_NOT_RECRUITING.

When did 3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis start?

3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis started on 2024-12-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.